We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
A jury sided with Amgen Wednesday in a suit accusing Regeneron and Sanofi of violating two of its patents when they developed a cholesterol-fighting biologic. Read More
Prescription drug prices rose 5.2 percent for customers of PBM Express Scripts in 2015, approximately half of the increase seen in 2014, the company stated Tuesday in its annual Drug Trend report. Read More
The FTC is arguing that a district court erred in failing to apply the Supreme Court ruling in FTC v. Actavis in a pay-for-delay case involving GlaxoSmithKline’s Wellbutrin XL antidepressant. Read More
Greater transparency of pharmaceutical pricing is the key to reducing the nation’s prescription drug tab, according to multiple comments sent to the Senate Finance Committee. Read More
Amgen has targeted Sandoz over alleged patent infringement for pursuing FDA approval to produce a generic version of its blockbuster drug Enbrel. Read More
A federal report finds that specialty drugs are driving overall spending on prescription drugs higher, although the full extent of their impact is difficult to calculate due to a lack of agreement on what constitutes a “specialty” drug. Read More